Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Trends in Immunology|July 6, 2020
The Contribution of Epigenetics to Cancer ImmunotherapyLorea Villanueva, Damiana Álvarez-Errico, Manel Esteller
Cancer Treatment Reviews|February 10, 2022
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysisGuillermo Villacampa, Pablo Tolosa, Fernando Salvador, et al.
Oncotarget|December 8, 2016
IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccinationDiana Llopiz, Marta Ruiz, Stefany Infante, et al.
Vaccine|March 6, 2012
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responsesFrancesc Rudilla, Catherine Fayolle, Noelia Casares, et al.
Cancer Treatment Reviews|April 18, 2022
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?Juan Miguel Cejalvo, Claudette Falato, Lorea Villanueva, et al.
Oncoimmunology|April 11, 2018
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancerLorea Villanueva, Leyre Silva, Diana Llopiz, et al.
Biomed Research International|October 5, 2013
A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivoLaura Arribillaga, Maika Durantez, Teresa Lozano, et al.
Cancer Immunology, Immunotherapy : CII|December 15, 2018
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma modelDiana Llopiz, Marta Ruiz, Lorea Villanueva, et al.
Journal of Medical Virology|October 9, 2015
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearanceAintzane Zabaleta, Jose-Ignacio Riezu-Boj, Esther Larrea, et al.
Cancers|November 19, 2020
Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular CarcinomaLeyre Silva, Josune Egea, Lorea Villanueva, et al.
Pageof 2